Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

9.125 -0.075 (-0.82%)

Streaming Delayed Price Updated: 2:03 PM EST, Jan 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Prothena Appoints David Ford to Newly Created Chief People Officer Position

March 04, 2024

From Prothena Corporation plc

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

February 29, 2024

Via Benzinga

Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate

February 21, 2024

From Prothena Corporation plc

Via Business Wire

Decoding 6 Analyst Evaluations For Prothena Corp ↗

February 16, 2024

Via Benzinga

Prothena Corp: Q4 Earnings Insights ↗

February 15, 2024

Via Benzinga

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

Earnings Outlook For Prothena Corp ↗

February 14, 2024

Via Benzinga

Navigating 5 Analyst Ratings For Prothena Corp ↗

January 25, 2024

Via Benzinga

Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights

February 15, 2024

From Prothena Corporation plc

Via Business Wire

Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

February 08, 2024

From Prothena Corporation plc

Via Business Wire

$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today ↗

January 22, 2024

Via Benzinga

Demystifying Prothena Corp: Insights From 5 Analyst Reviews ↗

January 09, 2024

Via Benzinga

4 Analysts Have This to Say About Prothena Corp ↗

December 18, 2023

Via Benzinga

Earnings Preview For Prothena Corp ↗

November 01, 2023

Via Benzinga

Expert Ratings for Prothena Corp ↗

October 23, 2023

Via Benzinga

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 30, 2024

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales

Via Benzinga

Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 09, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market...

Via Benzinga

Topics Stocks

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 08, 2024

Via Benzinga

Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday ↗

January 08, 2024

U.S. stocks traded mixed, with the Dow Jones index falling around 80 points on Monday. Shares of The Boeing Company (NYSE: BA) fell during Friday’s session after an exit door blew out of a 737 aircraft...

Via Benzinga

Topics Stocks

Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs

January 08, 2024

From Prothena Corporation plc

Via Business Wire

Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others ↗

November 21, 2023

Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this

Via Benzinga

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning ↗

November 17, 2023

Biotech companies are edging closer to finding the answers behind Alzheimer's disease.

Via Investor's Business Daily

8 Health Care Stocks Whale Activity In Today's Session ↗

November 07, 2023

Via Benzinga

Prothena Reports Third Quarter 2023 Financial Results and Business Highlights

November 02, 2023

From Prothena Corporation plc

Via Business Wire

Prothena to Report Third Quarter 2023 Financial Results on November 2

October 26, 2023

From Prothena Corporation plc

Via Business Wire

Biogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's Treatment ↗

October 26, 2023

Both companies are working on under-the-skin injections for Alzheimer's treatment.

Via Investor's Business Daily

Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 16, 2023

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

Via Benzinga

Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday ↗

October 16, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session.

Via Benzinga

Topics Stocks

Why Is Alzheimer's Player Prothena Stock Trading Higher Today? ↗

October 16, 2023

Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

All News about Prothena Corporation plc - Ordinary Shares